Combination therapy in the treatment of hypertension

Barry J Materson, Richard A Preston

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Evidence supports the concept that therapeutic reduction of intra-arterial pressure (blood pressure) well into the biologically normal range confers substantial protection against death and target organ damage associated with arterial hypertension. This is especially true for patients who also have diabetes mellitus, chronic renal disease, isolated systolic hypertension, or other cardiovascular risk factors. There is also evidence that most patients will require more than one drug in order to achieve these more aggressive therapeutic goals. Therefore, it has become appropriate to use more than one drug as initial therapy for such patients (1). Many commercially available combination products are now recommended for initial antihypertensive therapy.

Original languageEnglish (US)
Title of host publicationHypertension
Subtitle of host publicationPrinciples and Practice
PublisherCRC Press
Pages547-560
Number of pages14
ISBN (Electronic)9780849356001
ISBN (Print)0824728556, 9780824728557
StatePublished - Jan 1 2005

Fingerprint

Hypertension
Therapeutics
Chronic Renal Insufficiency
Pharmaceutical Preparations
Antihypertensive Agents
Diabetes Mellitus
Arterial Pressure
Reference Values
Blood Pressure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Materson, B. J., & Preston, R. A. (2005). Combination therapy in the treatment of hypertension. In Hypertension: Principles and Practice (pp. 547-560). CRC Press.

Combination therapy in the treatment of hypertension. / Materson, Barry J; Preston, Richard A.

Hypertension: Principles and Practice. CRC Press, 2005. p. 547-560.

Research output: Chapter in Book/Report/Conference proceedingChapter

Materson, BJ & Preston, RA 2005, Combination therapy in the treatment of hypertension. in Hypertension: Principles and Practice. CRC Press, pp. 547-560.
Materson BJ, Preston RA. Combination therapy in the treatment of hypertension. In Hypertension: Principles and Practice. CRC Press. 2005. p. 547-560
Materson, Barry J ; Preston, Richard A. / Combination therapy in the treatment of hypertension. Hypertension: Principles and Practice. CRC Press, 2005. pp. 547-560
@inbook{3c3d90e4b797454891a6c1272ae084ae,
title = "Combination therapy in the treatment of hypertension",
abstract = "Evidence supports the concept that therapeutic reduction of intra-arterial pressure (blood pressure) well into the biologically normal range confers substantial protection against death and target organ damage associated with arterial hypertension. This is especially true for patients who also have diabetes mellitus, chronic renal disease, isolated systolic hypertension, or other cardiovascular risk factors. There is also evidence that most patients will require more than one drug in order to achieve these more aggressive therapeutic goals. Therefore, it has become appropriate to use more than one drug as initial therapy for such patients (1). Many commercially available combination products are now recommended for initial antihypertensive therapy.",
author = "Materson, {Barry J} and Preston, {Richard A}",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
isbn = "0824728556",
pages = "547--560",
booktitle = "Hypertension",
publisher = "CRC Press",

}

TY - CHAP

T1 - Combination therapy in the treatment of hypertension

AU - Materson, Barry J

AU - Preston, Richard A

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Evidence supports the concept that therapeutic reduction of intra-arterial pressure (blood pressure) well into the biologically normal range confers substantial protection against death and target organ damage associated with arterial hypertension. This is especially true for patients who also have diabetes mellitus, chronic renal disease, isolated systolic hypertension, or other cardiovascular risk factors. There is also evidence that most patients will require more than one drug in order to achieve these more aggressive therapeutic goals. Therefore, it has become appropriate to use more than one drug as initial therapy for such patients (1). Many commercially available combination products are now recommended for initial antihypertensive therapy.

AB - Evidence supports the concept that therapeutic reduction of intra-arterial pressure (blood pressure) well into the biologically normal range confers substantial protection against death and target organ damage associated with arterial hypertension. This is especially true for patients who also have diabetes mellitus, chronic renal disease, isolated systolic hypertension, or other cardiovascular risk factors. There is also evidence that most patients will require more than one drug in order to achieve these more aggressive therapeutic goals. Therefore, it has become appropriate to use more than one drug as initial therapy for such patients (1). Many commercially available combination products are now recommended for initial antihypertensive therapy.

UR - http://www.scopus.com/inward/record.url?scp=84885177479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885177479&partnerID=8YFLogxK

M3 - Chapter

SN - 0824728556

SN - 9780824728557

SP - 547

EP - 560

BT - Hypertension

PB - CRC Press

ER -